08/30/2024 3:47 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:23 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024 3:08 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 10:47 AM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 8:52 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:17 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 2:34 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/30/2024 2:25 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 3:06 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:05 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 11:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024 12:16 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 9:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024 9:23 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024 3:09 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:11 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 8:54 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024 8:56 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 3:11 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:09 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 12:56 PM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 12:38 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 9:50 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024 10:48 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 3:08 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 9:05 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 9:51 AM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 12:13 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 3:21 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 12:45 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 2:32 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 7:36 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 7:25 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/15/2024 11:20 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 10:41 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 10:50 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2024 7:01 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/08/2024 7:54 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/03/2024 3:05 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 9:07 AM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024 3:15 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T | |
Sell NVDA Now? (Ad) Guess who's selling NVDA next
The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). |
04/16/2024 3:56 PM | Arjuna Capital (Filed by) Vertex Pharmaceuticals (Subject)
| Form PX14A6G | |
04/11/2024 3:08 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/11/2024 6:13 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 6:17 AM | Vertex Pharmaceuticals (Subject)
| Form SC TO-C | |
04/10/2024 4:22 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/10/2024 11:14 AM | Capital World Investors (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/04/2024 3:05 PM | Vertex Pharmaceuticals (Filer)
| Form ARS | |
02/27/2024 3:44 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:37 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:24 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 12:19 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 10:25 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 10:10 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:44 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:52 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:26 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 3:28 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:16 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:43 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:49 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:38 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:26 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:29 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 10:38 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:44 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:52 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:16 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:50 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:43 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 10:03 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 10:29 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:57 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:32 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:22 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:22 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 10:19 AM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 4:11 PM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 4:34 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:23 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 12:42 PM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 12:24 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 11:44 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 10:32 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 9:32 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 8:52 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 5:19 PM | Capital World Investors (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 3:38 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:40 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:43 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
War on Elon Escalates… (Ad) Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades.
By doing so he has put himself in the crosshairs of an ideological war with the global elites.
And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. Click here to learn how you can benefit from its widespread distribution. |
02/08/2024 3:45 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:47 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:20 PM | Ambrose Kristen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:10 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 3:09 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2024 3:06 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:56 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 3:17 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 9:32 AM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |